Department of Microbiology and Parasitology, Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brazil.
Department of Microbiology and Parasitology, Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brazil.
Biomed Pharmacother. 2017 Oct;94:374-379. doi: 10.1016/j.biopha.2017.07.113. Epub 2017 Aug 1.
The aim of this study was to evaluate the enzymatic activity of the purinergic system in sera samples from alloxan-induced diabetic mice treated with tucumã oil (Astrocaryum vulgare). For this, the mice were divided into four groups (n=6): control/water (the group CW); control/tucumã oil (the group CT); diabetic/water (the group DW), and diabetic/tucumã oil (the group DT) treated for 14days with 5.0mLkg via oral gavage. On day 14 post-treatment, mice were submitted to euthanasia and blood samples were collected by cardiac puncture. Tucumã oil treatment significantly decreased (p<0.05) blood glucose levels in the group DT compared to the group DW. These results demonstrated an increase (p<0.05) in NTPDase (adenosine triphosphate (ATP substrate) or adenosine diphosphate (ADP substrate)), 5'-nucleotidase (AMP substrate) and adenosine deaminase (ADA; adenosine substrate) activities in serum from the group DW compared to the group CW. Tucumã oil treatment prevented these alterations in the group DT compared to the group DW, and restored these parameters near to the group CW. In summary, the treatment with tucumã oil was able to modulate the alterations caused by hyperglycemia probably by the presence of carotenoids compounds, maintaining normal levels of ATP, ADP, AMP and adenosine, molecules that could exhibit anti-inflammatory properties, depending on their concentration. Thus, the tucumã oil is a promising natural compound with protective action against diabetes and its side effects, such as changes in the purinergic system, improving the immune system.
本研究旨在评估经桐拉油(Astrocaryum vulgare)处理的链脲佐菌素诱导的糖尿病小鼠血清样品中嘌呤能系统的酶活性。为此,将小鼠分为四组(每组 n=6):对照/水(CW 组);对照/桐拉油(CT 组);糖尿病/水(DW 组)和糖尿病/桐拉油(DT 组),通过口服灌胃给药 14 天,剂量为 5.0mLkg。在治疗后第 14 天,对小鼠进行安乐死,并通过心脏穿刺采集血液样本。与 DW 组相比,DT 组的桐拉油治疗显著降低了(p<0.05)血糖水平。这些结果表明,与 CW 组相比,DW 组血清中的 NTPDase(三磷酸腺苷(ATP 底物)或二磷酸腺苷(ADP 底物))、5'-核苷酸酶(AMP 底物)和腺苷脱氨酶(ADA;腺苷底物)活性增加(p<0.05)。与 DW 组相比,DT 组的桐拉油治疗预防了这些变化,并使这些参数恢复到接近 CW 组的水平。总之,桐拉油的治疗能够调节高血糖引起的变化,可能是由于类胡萝卜素化合物的存在,维持了 ATP、ADP、AMP 和腺苷的正常水平,这些分子可能具有抗炎特性,这取决于它们的浓度。因此,桐拉油是一种有前途的天然化合物,具有保护作用,可预防糖尿病及其副作用,如嘌呤能系统的变化,改善免疫系统。